BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 6205884)

  • 1. Monoclonal antibodies to polymorphic epitopes on Ia antigens: three independent groups of determinants expressed on DRw6 homozygous cells.
    Johnson JP; Wank R
    Eur J Immunol; 1984 Aug; 14(8):739-44. PubMed ID: 6205884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two-dimensional gel analysis of a second family of class II molecules by polymorphic HLA-DR4,5, and w9 monoclonal antibodies.
    Maeda H; Hirata R; Okuyama M; Thompson A; Tohyama H
    J Immunol; 1984 May; 132(5):2478-84. PubMed ID: 6201545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T cells specific for different antigens express different HLA-D region products.
    Schendel DJ; Johnson JP
    Eur J Immunol; 1985 Dec; 15(12):1239-43. PubMed ID: 3878791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ia molecular localization of the DRw52 allodeterminant and the DRw52-like determinants defined by monoclonal antibodies.
    Karr RW; Lipman LK; Alber C; Koning F; Goeken NE
    J Immunol; 1985 Oct; 135(4):2642-6. PubMed ID: 2411807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical dissection of DRw6 related epitopes using monoclonal antibodies.
    Johnson JP; Wank R
    Hum Immunol; 1986 May; 16(1):69-80. PubMed ID: 2423487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Monoclonal antibodies against determinants on human MHC class II antigens].
    Eichler W; Seifert M; Fiebig H
    Allerg Immunol (Leipz); 1990; 36(4):309-20. PubMed ID: 1711285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemistry of HLA-DRw6: evidence for seven distinct haplotypes.
    Haziot A; Lepage V; Freidel AC; Betuel H; Degos L; Charron DJ
    J Immunol; 1986 May; 136(10):3767-72. PubMed ID: 3486222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Separation of three class II antigens from a homozygous human B cell line.
    Shackelford DA; Lampson LA; Strominger JL
    J Immunol; 1983 Jan; 130(1):289-96. PubMed ID: 6600185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two-dimensional gel analysis of the polypeptides precipitated by a polymorphic HLA-DR1,2,w6 monoclonal antibody: evidence for a third locus.
    De Kretser TA; Crumpton MJ; Bodmer JG; Bodmer WF
    Eur J Immunol; 1982 Jul; 12(7):600-6. PubMed ID: 6811289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct epitopes of Ik gene products identified by monoclonal antibodies.
    Pierres M; Kourilsky FM; Rebouah JP; Dosseto M; Caillol D
    Eur J Immunol; 1980 Dec; 10(12):950-7. PubMed ID: 6162651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-reactions between mouse Ia and human HLA-D/DR antigens analyzed with monoclonal alloantibodies.
    Pierres M; Rebouah JP; Kourilsky FM; Dosseto M; Mercier P; Mawas C; Malissen B
    J Immunol; 1981 Jun; 126(6):2424-9. PubMed ID: 6785353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different specificities of an HLA-DRw6 haplotype detected by alloreactive T lymphocytes.
    Myers LK; Ball EJ; Stastny P
    Hum Immunol; 1984 Dec; 11(4):193-205. PubMed ID: 6210279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigenic heterogeneity of human colorectal cancer cell lines analyzed by a panel of monoclonal antibodies. I. Heterogeneous expression of Ia-like and HLA-like antigenic determinants.
    MacLean GD; Seehafer J; Shaw AR; Kieran MW; Longenecker BM
    J Natl Cancer Inst; 1982 Aug; 69(2):357-64. PubMed ID: 6180206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A monoclonal antibody to the HLA-DR product recognizes a polymorphic Ia determinant in mice.
    Brickell PM; McConnell I; Milstein C; Wright B
    Immunology; 1981 Jul; 43(3):493-501. PubMed ID: 6166548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA-DR-, MB- and novel DC-related determinants restrict purified protein derivative of tuberculin (PPD)-stimulated human T cell proliferation.
    Pawelec G; Schneider EM; Müller C; Wernet P
    Eur J Immunol; 1985 Jan; 15(1):12-7. PubMed ID: 2578396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptide vaccines incorporating a 'promiscuous' T-cell epitope bypass certain haplotype restricted immune responses and provide broad spectrum immunogenicity.
    Kaumaya PT; Kobs-Conrad S; Seo YH; Lee H; VanBuskirk AM; Feng N; Sheridan JF; Stevens V
    J Mol Recognit; 1993 Jun; 6(2):81-94. PubMed ID: 7508238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complexity of the supertypic HLA-DRw53 specificity: two distinct epitopes differentially expressed on one or all of the DR beta-chains depending on the HLA-DR allotype.
    Knowles RW; Flomenberg N; Horibe K; Winchester R; Radka SF; Dupont B
    J Immunol; 1986 Oct; 137(8):2618-26. PubMed ID: 2428870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical variation of human Ia like antigens detected with monoclonal antibodies.
    Cohen BB; Deane DL; Van Heyningen V; Guy K; Hutchins D; Moxley M; Steel CM
    Clin Exp Immunol; 1983 Jul; 53(1):41-50. PubMed ID: 6191895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Xenogeneic recognition of soluble and cell surface HLA class II antigens by proliferative murine T cells.
    Viguier M; Lotteau V; Charron D; Debré P
    Eur J Immunol; 1987 Nov; 17(11):1540-6. PubMed ID: 2960540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular identifications of HLA-DR4, MT3, and TB21 antigens on HLA-DR4 homozygous B cell lines.
    Maeda H; Hirata R
    J Immunol; 1984 Feb; 132(2):574-7. PubMed ID: 6418807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.